New heart drug enters Mid-Stage safety testing
NCT ID NCT06717074
Summary
This study is testing a new drug called RBD4059 to see if it is safe and might help people with stable coronary artery disease, a condition where the heart's arteries are narrowed. About 30 adults will receive either the drug or a placebo (inactive substance) through injections under the skin over several months. Researchers will closely monitor participants for side effects and check if the drug affects blood clotting factors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STABLE CORONARY ARTERY DISEASE CAD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ribocure Clinic
Mölndal, 43153, Sweden
Conditions
Explore the condition pages connected to this study.